D-0692-2017 Class III Terminated

Recalled by The Harvard Drug Group — Livonia, MI

FDA drug recall D-0692-2017 was initiated by The Harvard Drug Group on Dec 27, 2016 and is designated Class III. Reason for recall: Superpotent Drug; out of specification results for assay (manufacturer) The recall status is terminated (terminated Jul 27, 2017). Affected quantity: 36,990 tablets.

Recall details

Product Type
Drugs
Report Date
May 10, 2017
Initiation Date
Dec 27, 2016
Termination Date
Jul 27, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
36,990 tablets

Product description

Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04

Reason for recall

Superpotent Drug; out of specification results for assay (manufacturer)

Distribution pattern

Nationwide and PR

Code information

LOT: T-00601 Exp: 04-2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0692-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0692-2017. Report a data issue: hello@regdatalab.com.